IMPACT OF BIOLOGICAL THERAPY ON BONE IN PATIENTS WITH RHEUMATOID ARTHRITIS

• Main Authors: P. S. Dydykina, I. S. Dydykina, E. L. Nasonov
• Format: Article
• Language: Russian
• Published: IMA-PRESS LLC 2014-12-01
• Series: Научно-практическая ревматология
• Subjects: rheumatoid arthritis; secondary osteoporosis; bone mineral density; proinflammatory cytokines; biological agents
• Online Access: https://rsp.mediar-press.net/rsp/article/view/2013

The paper gives the data currently available in the literature on the impact of biological agents (BA) on bone mineral density, metabolism, and remodeling in rheumatoid arthritis (RA). These agents, by virtue of their high efficacy, are widely used to treat patients with RA. Since localized and generalized bone resorption and destruction play a prominent role in its pathogenesis, an investigation of the effect of BA on bone may be of essential interest. Activated osteoclastogenesis occurs because of an interaction between the immune and bone systems under the influence of different proinflammatory cytokines. The inhibition of the latter has been ascertained to not only reduce joint inflammation, but also to prevent localized and generalized osteoporosis. This review discusses the results of these trials and the issues of further investigations.